Imascope Inc.

Imascope has created the first hospital quality digital X-ray sensor that achieves the price requirements of small clinics. Just as digital cameras replaced photographic film within three years after a cost effective alternative became available, digital x-ray pictures will replace X-ray film. Demand for our sensor is strong, and we are preparing for first deliveries in February 2007. Imascope has already received letters of interest from distributors for over $4 million in the first year.

The Imascope sensor pays for itself in two years or less. Images are available immediately rather than waiting for a film to be developed and hoping the exposure is correct. The elimination of film and the caustic chemicals used to develop the film provides a welcome convenience in addition to the cost savings. Storage space is gained through the elimination of both the processor room and the need to store films. However, the greatest advantage of the digital images remains a better diagnostic ability through computer enhancement.

The key to the Imascope price breakthrough is proprietary technology developed with the National Optics Institute. The system gives an effective 16,384 shades of grey and a resolution matching top quality digital hospital systems that sell for 6 to 10 times the price. Also critical to our target market is the compact size of the system. This provides Imascope access to a retrofit market while the size of competitive products is generally too large.

The retrofit market for X-ray sensors to replace film cartridges is significant. The total retrofit base is about $US 15 billion using our selling price of $US 42,500. The first market to be addressed by Imascope is veterinarian clinics. There are 29,500 veterinarian clinics in Canada and the US, with 90% of them owning film based X-ray equipment. Europe has another 51,234 veterinarian systems. This translates to a $US 3.3 billion veterinarian opportunity. Sales into the human clinic market are planned to commence in April 2007.

John Brooks M.Sc., CFA - CEO. Mr. Brooks brings a blend of financial and life science experience. He has taken two life science companies through an IPO on the main TSX exchange. He was a Director and Chair of the Finance Committee at BioteCanada and was a VP at CIBC Wood Gundy. He was named as the Ottawa Innovator of the year, was a finalist as the Ottawa Businessperson of the Year and was named one of the top 10 people in Ottawa by Ottawa Life Magazine.

John Brooks CEO
Imascope Inc.
925 Carriere, Suite 10
Gatineau, Quebec J8Y 6W5

819-777-7979
613-822-5195 (fax)
jbrooks@imascope.ca